Why biotech & pharma companies use PreVeil

In biotech and pharma, one of the biggest worries for CISOs, boards and audit committees is the loss of their IP. Consequently, many companies have policies preventing the use of any standard email platforms like Outlook or Gmail. These firms fear man-in-the-middle attacks will compromise their valuable IP. Additionally, potential phishing attacks through email could make the whole network vulnerable. With PreVeil however, the enterprise is ensured to have a secure email platform that allows biotech and pharma to access emails without compromise.

Taller walls don’t work

For many pharma companies and biotechs, email serves as a source of vulnerability. Attachments, hyperlinks or PDFs can present a way for intruders to enter the company’s environment. And given that life sciences represent some of the highest-value targets for attackers, experts agree it is not a question of ‘if’ a firm will be breached but rather ‘when’. To survive in this context, biotech firms and pharma need better protection for their sensitive emails. PreVeil provides this protection through its radically different approach to encryption.

End to end encryption added to your stack

According to the Ponemon Institute, effective end-to-end encryption is one of the most effective efforts a company can take to improve the security of its data. Indeed, end-to-end encryption is the gold standard of encryption processes as it ensures that the data that resides in an email cannot be read by third parties. At PreVeil, we use end-to-end encryption to ensure your email is cryptographically encoded so that the only persons who can decrypt your emails are you and the person(s) receiving your messages.

Manage internal employees

IT and Security deputies fear email phishing attacks. And rightly so. Fewer than 3% of phishing attack recipients report suspicious emails to their IT departments. At the same time, over 30% of recipients open the emails containing the phishing attack. PreVeil however provides a closed and managed community for email use which disables potential spoof emails or eFail-type attacks.

Compliance: Fully auditable with ability to roll back changes

Consistent with FDA requirements, PreVeil cryptographically prevents unauthorized modification by ensuring unauthorized users cannot modify shared records without being granted permission by the file owner. All changes to file or email stored in PreVeil are cryptographically logged, time stamped, and auditable by administrators and regulators. All emails, file modifications, and other actions within PreVeil are also digitally signed.

Experience a Live Demo

See PreVeil in action